Apex Trader Funding (ATF) - News
Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing
Emergent BioSolutions Inc (NYSE:EBS), through its subsidiary Emergent Manufacturing Operations Baltimore, has reached a settlement with Janssen Pharmaceuticals, Inc., a branch of Johnson & Johnson (NYSE:JNJ), resolving disputes related to the manufacturing of Johnson & Johnson’s investigational COVID-19 vaccine.
This settlement ends claims arising from their manufacturing services agreement and related arbitration.
Related: Why Is Vaccine Maker Emergent BioSolutions Stock Trading Higher On Tuesday?
Under the confidential Settlement Agreement and Release terms, ...